Compositions comprising inhibitors of microsomal triglyceride transfer protein and apo-b secretion
AssigneeRedux Therapeutics, LLC
InventorsEnoch KIM, Paul SWEETNAM
Life of this patent
Estimating the term…
Loading patent…
AssigneeRedux Therapeutics, LLC
InventorsEnoch KIM, Paul SWEETNAM
Estimating the term…
The present invention relates to pharmaceutical composition(s) comprising particles comprising one or more compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion, wherein at least 50% of the particles are characterized by a volume particle fraction less than 10 μm, more preferably less than 5 μm, more preferably less than 2.5 μm. The pharmaceutical composition can be useful for the prevention and treatment of various diseases, particularly atherosclerosis and its clinical sequelae, for lowering serum lipids, and related ailments. The invention further relates to methods of treating diseases, such as hypertriglyceridemia, hyperchylomicronemia, atherosclerosis, obesity, and related conditions using the compounds. A method for decreasing apolipoprotein B (apo B) secretion is also provided.
A composition comprising particles comprising a compound represented by Formula 1:
6-7. (canceled)
(canceled)
The method of claim 17, wherein the disorder is a loss of intestinal homeostasis.
The method of claim 17, wherein orally administering a composition according to claim 1 results in an inhibition of absorption, assembly, and/or transport of lipids, cholesterol, and/or microbial metabolites in the GI tract of the subject.
22-26. (canceled)
30-34. (canceled)
Dependencies are inferred from the claim text.